Antidepressants Flashcards

1
Q

Tricyclic Antidepressants (TCA):

A

amitriptyline (Elavil), desipramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Selective Serotonin Reuptake Inhibitors (SSRI):

A

fluoxetine, paroxetine, sertraline, (2nd gen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Serotonin & Norepinephrine Reuptake Inhibitors (SNRI):

A

venlafaxine (2nd gen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Monoamine Oxidase Inhibitors (MAOI):

A

phenelzine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Atypical antidepressants (tetracyclic and
unicyclic antidepressants):

A

mirtazapine (tetracyclic), bupropion (unicyclic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 4 domains/Sx’s of depression?

A

Emotional:
- Reduced pleasure, reduced interest in usual activities
- Pessimistic outlook
- Anxiety

Physical:
- Fatigue, sleep disorders (insomnia), appetite disturbances

Cognitive:
- Poor concentration, slow thinking, poor short-term memory, confusion

Psychomotor:
- Agitation
- Slowed speech

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the Serotonin hypothesis?

A

Depression is related to reduced synaptic levels of serotonin
- 1950’s – Reserpine caused depression in 15% of patients (can downreg. serotonin)
- Most antidepressant drugs appear to work by enhancing synaptic monoamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the functions of serotoninergic system?

A
  • Mood
  • Memory processing
  • Cognition
  • Sleep
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 5 steps of Serotonin neurotransmission?

A
  1. Synthesis
  2. Storage
  3. Release
  4. Bind to receptors
  5. Degradation / termination *
    - Uptake by presynaptic serotonin transporter(SERT)
    - Monoamine oxidase (MAO)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the main target of current Antidepressants?

A

Degradation / termination
- Uptake by presynaptic serotonin transporter(SERT)
- Monoamine oxidase (MAO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antidepressants have a _______ onset

A

SLOW

it takes at least 2 weeks to generate therapeutic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the action site of TCA’s?

A

Inhibit serotonin and norepinephrine uptake similarly (therapeutic);

Anti-muscarinic, anti-histaminic and anti-adrenergic (α) actions (adverse effects).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the therapeutic uses of TCA’s?

A

depression; chronic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the adverse effects of TCA’s?

A

Sexual dysfunction

Antagonize muscarinic r’s (CNS: confusion, ANS: constipation, dry mouth)

Antagonize a-adrenergic r’s (orthostatic hypo, reflex tachy)

Antagonize histamine (sedation, weight gain)

Overdoses are potential problems (–> coma, resp. depression, seizures & cardiac arrhythmias)

Interact with SSRIs (CYP2D6 inhibitor)

Interact with sedatives, sympathomimetics, antimuscarinics

NOT recom., for elderly pt’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the action sites of SSRI’s?

A

inhibit serotonin reuptake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the therapeutic uses of SSRI’s?

A

First-line treatment (Are safer than TCAs and MAOIs; not more effective than TCAs and MAOIs);

Depression; Anxiety (GAD, PTST, OCD..);

Fluoxetine for bulimia.

17
Q

What are the adverse effects of SSRI’s?

A

Safer in general;

Sexual dysfunction, weight gain;

Interact with β blockers and TCAs, interact with MAOIs (serotonin syndrome)

18
Q

What are the action sites of SNRI’s?

A

Inhibit both serotonin and NE reuptake;

19
Q

What are the therapeutic uses of SNRI’s?

A

depression; anxiety;

20
Q

What are the adverse effects of SNRI’s?

A

Sexual dysfunction;

Sympathetic symptoms;

Interact with MAOIs (serotonin syndrome)

21
Q

What are the action sites of MAOI’s?

A

Inhibit monoamine oxidase (metabolism enzyme) → increase monoamines.

22
Q

What are the therapeutic uses of MAOI’s?

A

depression; usually reserved for patients who don’t respond to other agents.

23
Q

What are the adverse effects of MAOI’s?

A

sexual dysfunction; weight gain; overdose

Interact with SSRIs, SNRIs, TCAs (serotonin syndrome); interact with foods containing tyramine.

24
Q

What are the action sites of Atypical’s?

A

Mirtazapine (Remeron)
Action sites:
- Structurally a tetracyclic compound
- Increasing norepinephrine and serotonin release
- Potent blocker of histamine H1 receptors

Bupropion:
Action sites:
- Structurally an unicyclic compound
- Largely unknown; No direct effects on the serotonin system.

25
Q

What are the therapeutic uses of Atypical’s?

A

Mirtazapine (Remeron)
- Depression that is unresponsive to SSRI and SNRI
- Might be added to an SSRI or SNRI to augment
antidepressant benefit

Bupropion:
- Might be added to an SSRI or SNRI to augment antidepressant→ benefit if monotherapy is unsuccessful.
- Smoking cessation.
- Have some benefits in treating obesity.

26
Q

What are the adverse effects of the Atypicals?

A

Mirtazapine (Remeron)
- Sedation
– Drug interactions: may be additive with those of CNS
depressants such as alcohol and benzodiazepines
- Weight gain
- not commonly associated with sexual effects.

Bupropion:
- Can include headache, dizziness, insomnia, seizures: much lower incidence than TCA’s
- No sexual dysfunction, no weight gain, and no sedation adverse effects
- Drug interactions: inhibit CYP 2D6
– Interact with many drugs such as β blockers and TCAs
→ increase plasma β blockers and TCAs levels.

27
Q

How long do Antidepressants take to generate therapeutic effects?

A

take at least 2 weeks

28
Q

SSRIs are…

A

first-line agents for MDD and anxiety disorders.

29
Q

SNRI’s are…

A

also first-line agents for MDD.

30
Q

TCAs and MAOIs:

A
  • second- or third-line treatments for MDD.
  • is reserved for patients who have been unresponsive to other agents.
31
Q

Mirtazapine and bupropion:

A
  • Mirtazapine: SSRI or SNRI non-responders
  • Added on drugs for an SSRI or SNRI
  • No sexual dysfunction adverse effects.